Bibliographic Details
| Title: |
Tadalafil-induced improvement in left ventricular diastolic function in resistant hypertension. |
| Authors: |
Santos, Rodrigo, Faria, Ana, Barbaro, Natália, Modolo, Rodrigo, Ferreira-Melo, Silvia, Matos-Souza, José, Coelho, Otávio, Yugar-Toledo, Juan, Fontana, Vanessa, Calhoun, David, Moreno, Heitor |
| Superior Title: |
European Journal of Clinical Pharmacology; Feb2014, Vol. 70 Issue 2, p147-154, 8p, 1 Diagram, 2 Charts, 2 Graphs |
| Subject Terms: |
AMBULATORY blood pressure monitoring, BLOOD pressure, CLINICAL trials, CROSSOVER trials, ECHOCARDIOGRAPHY, LEFT heart ventricle, HEART physiology, HYPERTENSION, NITRITES, NUCLEOTIDES, PEPTIDE hormones, RESEARCH funding, T-test (Statistics), PRE-tests & post-tests, BLIND experiment, TADALAFIL, DESCRIPTIVE statistics |
| Geographic Terms: |
BRAZIL |
| Abstract: |
Purpose: Left ventricular hypertrophy and diastolic dysfunction (LVDD) remain highly frequent markers of cardiac damage and risk of progression to symptomatic heart failure, especially in resistant hypertension (RHTN). We have previously demonstrated that administration of sildenafil in hypertensive rats improves LVDD, restoring phosphodiesterase type 5 (PDE-5) inhibition in cardiac myocytes. Methods: We hypothesized that the long-acting PDE-5 inhibitor tadalafil may be clinically useful in improving LVDD in RHTN independently of blood pressure (BP) reduction. A single blinded, placebo-controlled, crossover study enrolled 19 patients with both RHTN and LVDD. Firstly, subjects received tadalafil (20 mg) for 14 days and after a 2-week washout period, they received placebo orally for 14 days. Patients were evaluated by office BP and ambulatory BP monitoring (ABPM), endothelial function (FMD), echocardiography, plasma brain natriuretic peptide (BNP-32), cyclic guanosine monophosphate (cGMP) and nitrite levels. Results: No significant differences were detected in BP measurements. Remarkably, at least four echocardiographic parameters related with diastolic function improved accompanied by decrease in BNP-32 in tadalafil use. Although increasing cGMP, tadalafil did not change endothelial function or nitrites. There were no changes in those parameters after placebo. Conclusion: The current findings suggest that tadalafil improves LV relaxation through direct effects PDE-5-mediated in the cardiomyocytes with potential benefit as an adjunct to treat symptomatic subjects with LVDD such as RHTN patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Clinical Pharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
